Registry tracking care and outcomes for people with cardiogenic shock in Poland
Records how cardiogenic shock is diagnosed, treated and how patients fare in Poland.
Plain-language title generated from the registry record
Registry title: Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock
Key facts
- Where
- Wroclaw, PolandSee the 2 sites
Where in Poland
- Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, PolandWroclaw, PolandNot yet recruiting
- Wroclaw Medical UniversityWroclaw, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wroclaw Medical University
- Trial code
- NCT06697093
- Record updated
- 2 April 2025
- Original description
The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support.Read full original descriptionShow less
Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock CaS-POL
The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support.
It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.
Inclusion: Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E; age > 18 years old; persistent hemodynamic failure defined as systolic blood pressure of <90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs.
Exclusion: end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation; patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR); primary septic, anaphylactic, hypovolemic shock; post-operative cardiogenic shock.